BioSpace News Archive

Drug Development

Humacyte’s Engineered Blood Vessels in Final Push Toward BLA

Humacyte’s engineered blood vessels, human acellular vessels, are in a position to take tissue regeneration from a laboratory possibility to a commercial reality.

May 3, 2022
·
5 min read
·
Gail Dutton
Business

Dianthus Debuts with $100M and a Mission to Make Autoimmunity Less Inconvenient

Dianthus Therapeutics launched today with $100 million in Series A financing led by 5AM Ventures, Avidity Partners and Fidelity Research and Management. The company plans to tackle severe and rare autoimmune diseases by utilizing antibodies that target complements.

May 3, 2022
·
3 min read
·
Hayley Shasteen
Business

Teva Holds off Huntington’s Competitor, Resolves Opioid Cases

Teva announced that it had reached a deal with Lupin over Lupin’s Abbreviated New Drug Application (ANDA) for generic deutetrabenazine - an upcoming competitor to Hungtington’s drug Austedo.

May 3, 2022
·
3 min read
·
Mark Terry
Business

Vounatsos Out as Biogen Appears to Concede Defeat Over Aduhelm

Biogen announced the leadership change in its quarterly financial report. Michel Vounatsos plans to depart the company when a new CEO is found.

May 3, 2022
·
3 min read
·
Alex Keown
Business

Denali/Sanofi ALS Candidate Hits Phase II as Awareness Month Begins

Denali Therapeutics, Inc. has announced that dosing has begun for participants of a Phase II clinical trial that intends to evaluate the potential of SAR443820 (DNL788) in patients with amyotrophic lateral sclerosis (ALS).

May 3, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Business

Genesis and Lilly Ink AI Collab Worth Up to $670M

Genesis Therapeutics and Eli Lilly have entered into a strategic collaboration to discover novel therapies utilizing Genesis’ AI platform.

May 3, 2022
·
2 min read
·
Hayley Shasteen
Career Advice

How to Land a Biotech Job, According to Experts

We sat down with Associate Director of Talent Acquisition Jennifer Metivier and Chief People Officer Jennifer Peterson of Obsidian Therapeutics to discuss what type of candidates they prefer.

May 3, 2022
·
6 min read
·
Kaley Lefevre
Policy

Extradited Scientist Found Guilty of Stealing GSK Secrets

Gongda Xue has been found guilty in a Philadephia courtroom of stealing trade secrets from GlaxoSmithKline. This comes after his sister, Yu Xue, was also convicted for a similar crime.

May 3, 2022
·
3 min read
·
Alex Keown
Business

Anticipating FDA Rejection, Spero Cuts 75% Of Workforce

Spero is reducing a huge chunk of its staff to minimize expenses and reallocate resources toward more promising projects in anticipation of the FDA’s decision on its NDA for tebipenem HBr.

May 3, 2022
·
2 min read
·
Vanessa Doctor, RN
Pfizer Leans Heavily on COVID-19 Vaccine, Treatments in Q1

Pfizer reported first-quarter revenues of $25.7 billion, a whopping 82% operational growth. This growth was largely driven by its COVID-19 vaccine developed with BioNTech and its antiviral drug, Paxlovid.

May 3, 2022
·
3 min read
·
Mark Terry